FK 506-mediated T-cell apoptosis induction.
Migita
K
K
First Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan. migita@netn.agasaki-u.ac.jp
Eguchi
K
K
D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D016572:Cyclosporine / Q000494:pharmacology; D053938:DNA Fragmentation; D004768:Enterotoxins / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects; D051379:Mice; D008807:Mice, Inbred BALB C; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000032:analysis; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000276:immunology; D013154:Spleen / Q000276:immunology; D018089:Superantigens / Q000494:pharmacology; D013601:T-Lymphocytes / Q000166:cytology / Q000187:drug effects* / Q000276:immunology; D016559:Tacrolimus / Q000494:pharmacology*; D051020:bcl-X Protein
C494812:Bcl2l1 protein, mouse; D004768:Enterotoxins; D019253:Proto-Oncogene Proteins c-bcl-2; D016693:Receptors, Antigen, T-Cell, alpha-beta; D018089:Superantigens; D051020:bcl-X Protein; C031818:enterotoxin B, staphylococcal; D016572:Cyclosporine; D016559:Tacrolimus